Skip to main content
Japan Tissue Engineering Co., Ltd. logo

Japan Tissue Engineering Co., Ltd. — Investor Relations & Filings

Ticker · 7774 ISIN · JP3389610001 T Manufacturing
Open in API
Filings indexed 64 across all filing types
Latest filing 2026-05-01 Regulatory Filings
Country JP Japan
Listing T 7774

About Japan Tissue Engineering Co., Ltd.

https://www.jpte.co.jp/en/

Japan Tissue Engineering Co., Ltd. (J-TEC) is a company focused on the commercialization and industrialization of regenerative medicine. It develops, manufactures, and sells tissue-engineered medical products. The company operates through three primary business segments: the Regenerative Medicine Business, which provides its own therapeutic products such as autologous cultured cartilage and epidermis; the Custom Development & Manufacturing (CDMO) Business, offering contract services to support other developers in the field; and the LabCyte Business, which supplies cultured human tissue models for research and safety assessment purposes. J-TEC aims to establish regenerative medicine as a standard of care in healthcare.

Recent filings

Filing Released Lang Actions
（訂正）「事業計画及び成長可能性に関する事項」の一部訂正について
Regulatory Filings
2026-05-01 Japanese
投資有価証券評価損（特別損失）の計上および通期業績予想の修正に関するお知らせ
Regulatory Filings
2026-04-24 Japanese
確認書
Regulatory Filings Classification · 100% confidence The document is titled '確認書' (Confirmation Letter) and explicitly cites '金融商品取引法第24条の５の２第１項' (Article 24-5-2, Paragraph 1 of the Financial Instruments and Exchange Act). It serves as an officer certification confirming the accuracy of a semi-annual report. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations, even if they reference a report (like a semi-annual report), should be classified as Regulatory Filings (RNS) rather than the report itself. H1 28
2025-11-13 Japanese
半期報告書－第28期(2025/04/01－2026/03/31)
Interim / Quarterly Report Classification · 100% confidence The document is a '半期報告書' (Semi-Annual Report) filed by Japan Tissue Engineering Co., Ltd. with the Tokai Finance Bureau under the Financial Instruments and Exchange Act. It contains detailed financial statements, management analysis (MD&A), and business performance data for the interim period (April 1, 2025, to September 30, 2025). This fits the definition of an Interim/Quarterly Report (IR) as it provides comprehensive financial data for a period shorter than a full fiscal year. H1 2026
2025-11-13 Japanese
臨時報告書
AGM Information Classification · 100% confidence The document is titled "臨時報告書" (Extraordinary Report) and explicitly states in Section 1 that it is being submitted because resolutions were passed at the company's 27th Annual General Meeting (定時株主総会) held on June 19, 2025, pursuant to Japanese financial regulations (FIEA Article 24-5, Paragraph 4). Section 2 details the resolutions passed, including capital reduction, election of directors and auditors, and approval of retirement benefits. This structure—reporting the results of a shareholder meeting—is characteristic of an AGM Results announcement. Since the document reports the *results* of the AGM, the most specific code is AGM-R (AGM Information/Results). It is not a general regulatory filing (RNS) because it fits a specific category, nor is it a proxy statement (PSI) as it reports past events, not solicits votes.
2025-06-19 Japanese
内部統制報告書－第27期(2024/04/01－2025/03/31)
Governance Information Classification · 100% confidence The document is explicitly titled "内部統制報告書" (Internal Control Report) in the cover page and throughout the text. It references the Financial Instruments and Exchange Act (金融商品取引法第24条の４の４第１項) and details the framework, scope, criteria (based on the Financial Accounting Standards Board's framework), and the conclusion of the internal control assessment as of the fiscal year-end (March 31, 2025). This content aligns perfectly with the requirements for an Audit Report / Information filing, specifically concerning internal controls over financial reporting, which falls under the 'AR' category as defined, distinguishing it from a full Annual Report (10-K) or a simple Earnings Release (ER).
2025-06-19 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.